17th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200121654 | HUMAN THERAPEUTIC AGENTS | 2020-04-23 |
20200121655 | 2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS | 2020-04-23 |
20200121656 | METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA | 2020-04-23 |
20200121657 | SUBSTITUTED METHANOPYRIDO [2, 1-a] ISOINDOLONES AS mAChR MODULATORS FOR TREATING VARIOUS ASSOCIATED PATHOPHYSIOLOGICAL CONDITIONS AND PROCESS FOR PREPARATION THEREOF | 2020-04-23 |
20200121658 | CYCLOPAMINE ANALOGS | 2020-04-23 |
20200121659 | METHODS OF TREATING OPHTHALMIC DISEASE/DISORDER OR INJURY WITH IBUDILAST | 2020-04-23 |
20200121660 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | 2020-04-23 |
20200121661 | METHODS FOR THE TREATMENT OF CANCER METASTASIS | 2020-04-23 |
20200121662 | Non-Aqueous Liquid Nimodipine Compositions | 2020-04-23 |
20200121663 | B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS | 2020-04-23 |
20200121664 | INTRAVAGINALLY APPLICABLE DEVICES COMPRISING ANTIVIRAL COMPOUNDS | 2020-04-23 |
20200121665 | PPAR GAMMA MODULATORS FOR TREATING CYSTIC DISEASES | 2020-04-23 |
20200121666 | TAU PHOSPHORYLATION INHIBITORS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE | 2020-04-23 |
20200121667 | Inhibitors Of The Interaction Between MDM2 And P53 | 2020-04-23 |
20200121668 | USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY | 2020-04-23 |
20200121669 | METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND | 2020-04-23 |
20200121670 | MULTI-PHASE DELIVERY COMPOSITIONS AND PRODUCTS INCORPORATING SUCH COMPOSITIONS | 2020-04-23 |
20200121671 | C-Met Modulator Pharmaceutical Compositions | 2020-04-23 |
20200121672 | EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION | 2020-04-23 |
20200121673 | ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE | 2020-04-23 |
20200121675 | A TOPICAL COMPOSITION FOR TREATING ROSACEA AND A METHOD FOR TREATING ROSACEA WITH THE SAME | 2020-04-23 |
20200121676 | TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION | 2020-04-23 |
20200121677 | SUBSTITUTED 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2020-04-23 |
20200121678 | PYRIDAZINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS | 2020-04-23 |
20200121679 | THE USE OF A H3R INVERSE AGONIST FOR THE TREATMENT OF SHIFT WORK DISORDER | 2020-04-23 |
20200121680 | METHODS OF ADMINISTERING ELAGOLIX | 2020-04-23 |
20200121681 | METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION | 2020-04-23 |
20200121682 | COMPOSITIONS AND METHODS FOR TREATMENT OF FRAGILE X SYNDROME | 2020-04-23 |
20200121683 | METHODS OF TREATING OR PREVENTING PRETERM LABOR | 2020-04-23 |
20200121684 | MODULATORS OF BTK PROTEOLYSIS AND METHODS OF USE | 2020-04-23 |
20200121685 | Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis with Baricitinib | 2020-04-23 |
20200121686 | N-(SUBSTITUTED-PHENYL)-SULFONAMIDE DERIVATIVES AS KINASE INHIBITORS | 2020-04-23 |
20200121687 | Compounds and Compositions for Ossification and Methods Related Thereto | 2020-04-23 |
20200121688 | SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS | 2020-04-23 |
20200121689 | USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER | 2020-04-23 |
20200121690 | SALT OF SUBSTITUTED UREA DERIVATIVE AND USE THEREOF IN MEDICINE | 2020-04-23 |
20200121691 | 4-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | 2020-04-23 |
20200121692 | Meloxicam for the treatment of respiratory diseases in pigs | 2020-04-23 |
20200121693 | Use of Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV Therapy | 2020-04-23 |
20200121694 | TREATMENT OF NEUROPSYCHIATRIC DISORDERS WITH NEUROSTEROIDS AND ANALOGUES THEREOF | 2020-04-23 |
20200121695 | COMPOSITIONS AND METHODS FOR TREATING ITCH, SKIN INFLAMMATION, AND PRURITUS | 2020-04-23 |
20200121696 | NON-INFECTIVE NASAL SYMPTOM MANAGEMENT COMPOSITIONS AND METHODS | 2020-04-23 |
20200121697 | METHODS FOR DIAGNOSING AND TREATING CACHEXIA | 2020-04-23 |
20200121698 | DRY POWDER FORMULATIONS FOR INHALATION | 2020-04-23 |
20200121699 | COMBINATION THERAPIES COMPRISING IMMUNO-ONCOLOGY AGENTS AND BELINOSTAT | 2020-04-23 |
20200121700 | WOUND HEALING PROMOTER | 2020-04-23 |
20200121701 | TRIAZOLE BISPHOSPHONATE GERANYLGERANYL DIPHOSPHATE SYNTHASE INHIBITORS | 2020-04-23 |
20200121702 | A NUTRITIONAL COMPOSITION FOR USE TO ENHANCE ATTENTION AND/OR REDUCE IMPULSIVITY | 2020-04-23 |
20200121703 | CANCER TREATMENT | 2020-04-23 |
20200121704 | METHODS FOR TREATING HYPERTENSION AND ARTERIAL STIFFNESS | 2020-04-23 |
20200121705 | METHODS OF TREATING SEPSIS USING ANTI-SEPSIS LIPID A (ASLA) BASED THERAPEUTICS | 2020-04-23 |
20200121706 | METHOD FOR INHIBITING MYOPIA AND APPLICATION IN PREPARING DRUG | 2020-04-23 |
20200121707 | PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT OR PREVENTION, METHOD, AND USE THEREOF | 2020-04-23 |
20200121708 | METHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS | 2020-04-23 |
20200121709 | NADH COMPOUND COMPOSITION, AND PREPARATION AND USE THEREOF | 2020-04-23 |
20200121710 | DOUBLE-STRANDED NUCLEIC ACID MOLECULE, DNA, VECTOR, CANCER CELL GROWTH INHIBITOR, CANCER CELL MIGRATION INHIBITOR, AND DRUG | 2020-04-23 |
20200121711 | TREATMENTS FOR RETINAL DISORDERS | 2020-04-23 |
20200121712 | AGENT TO BE APPLIED TO OPHTHALMIC DEVICE | 2020-04-23 |
20200121713 | SHEAR-THINNING HYDROGEL, KIT AND METHOD OF PREPARATION | 2020-04-23 |
20200121714 | PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF | 2020-04-23 |
20200121715 | Composition comprising aqueous medium with reduced size water clusters to improve bioavailability of the aqueous medium and methods for making and using the compositions | 2020-04-23 |
20200121716 | Method for Inhibiting Both Glycolysis and Glutamine Metabolism in Cells and Use Thereof | 2020-04-23 |
20200121717 | POTASSIUM PHOSPHATES COMPOSITION FOR INJECTION | 2020-04-23 |
20200121718 | COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT | 2020-04-23 |
20200121719 | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS | 2020-04-23 |
20200121720 | NK-92 CELLS AND IL-15 AGONIST COMBINATION THERAPY | 2020-04-23 |
20200121721 | METHODS FOR GENETIC MODIFICATION OF HEMATOPOIETIC CELLS | 2020-04-23 |
20200121722 | USE OF COMPOSITION COMPRISING STEM CELL-DERIVED EXOSOME AS EFFECTIVE INGREDIENT FOR SUPPRESSION OR ALLEVIATION OF PRURITUS | 2020-04-23 |
20200121723 | USE OF COMPOSITION COMPRISING EXOSOME DERIVED FROM ADIPOSE-DERIVED STEM CELL AS EFFECTIVE INGREDIENT IN AMELIORATING DERMATITIS | 2020-04-23 |
20200121724 | COMPOSITIONS AND METHODS FOR GLAUCOMA | 2020-04-23 |
20200121725 | COMPOSITIONS AND METHODS FOR NEURALGENESIS | 2020-04-23 |
20200121726 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OSTEOARTHRITIS | 2020-04-23 |
20200121727 | METHODS AND COMPOSITIONS FOR TREATING SKELETAL MUSCULAR DYSTROPHY | 2020-04-23 |
20200121728 | Prevention and Treatment of Teratoma Formation in Stem Cell-Based Therapies Using Alternating Electric Fields | 2020-04-23 |
20200121729 | EXTRACELLULAR VESICLES FROM STEM CELLS TO TREAT AND/OR PREVENT DISEASE | 2020-04-23 |
20200121730 | Compositions and methods for reducing methane producing bacteria in animals | 2020-04-23 |
20200121731 | ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS) | 2020-04-23 |
20200121732 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO | 2020-04-23 |
20200121733 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO | 2020-04-23 |
20200121734 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO | 2020-04-23 |
20200121735 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO | 2020-04-23 |
20200121736 | COMPOSITIONS OF MICROBIOTA AND METHODS RELATED THERETO | 2020-04-23 |
20200121737 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | 2020-04-23 |
20200121738 | METHODS AND COMPOSITIONS RELATING TO ISOLATED AND PURIFIED MICROBES | 2020-04-23 |
20200121739 | BACTERIA FOR TREATING CANCER | 2020-04-23 |
20200121740 | PHARMACEUTICAL COMPOSITIONS CONTAINING PEDIOCOCCUS AND METHODS FOR REDUCING THE SYMPTOMS OF GASTROENTEROLOGICAL SYNDROMES | 2020-04-23 |
20200121741 | Methods And Means For Protecting The Skin Against Pathogenic Microorganisms | 2020-04-23 |
20200121742 | COMPOSITIONS FOR TREATING INFLAMMATION AND USES THEREOF | 2020-04-23 |
20200121743 | METHOD AND SYSTEM FOR REDUCING THE LIKELIHOOD OF DEVELOPING LIVER CANCER IN AN INDIVIDUAL DIAGNOSED WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2020-04-23 |
20200121744 | COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND MAINTAINING HEALTHY SKIN | 2020-04-23 |
20200121745 | COMPOSITIONS AND METHODS FOR CANCER THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS | 2020-04-23 |
20200121746 | ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF | 2020-04-23 |
20200121747 | COMPOSITION FOR PREVENTING OR TREATING ARTHRITIS COMPRISING HYDROQUINOIC ACID | 2020-04-23 |
20200121748 | CANNABIS FORMULATION AND METHOD OF PREPARATION | 2020-04-23 |
20200121749 | PHARMACEUTICAL COMPOSITION CONTAINING EXTRACT OF LEAVES OF VACCINIUM BRACTEATUM THUNB. FOR PREVENTION OR TREATMENT OF STRESS DISEASE AND DEPRESSION | 2020-04-23 |
20200121751 | ABORTION MEDICATIONS AND ADMINISTRATION METHOD THEREOF | 2020-04-23 |
20200121752 | PROCESS FOR OBTAINING A TANNIN EXTRACT ISOLATED FROM GRAPES, TANNIN EXTRACT OBTAINED AND USES THEREOF | 2020-04-23 |
20200121753 | METHOD FOR TREATING OR ALLEVIATING AUTOIMMUNE-RELATED DISEASES | 2020-04-23 |
20200121754 | RETINYLAMINE DERIVITIVES FOR TREATMENT OF OCULAR DISORDERS | 2020-04-23 |
20200121755 | THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA | 2020-04-23 |